Infarmed gave the green light to three new cannabis derivatives in Portugal, which are now available in pharmacies and are part of the arsenal of options...
The multinational Tilray, listed on the New York Stock Exchange, announced the acquisition of eight brands from brewer Anheuser-Busch, in a deal worth US$85 million. The business...
The start of the year for cannabis giant Tilray, listed on the New York Stock Exchange Nasdaq, began with the announcement of a new company strategy. Second...
Tilray Brands (NASDAQ | TSX: TLRY) announced in a press release the acquisition of Montauk Brewing Company, the most famous craft brewery in Greater...
Sales of cannabis for medicinal purposes in Portugal are still not very expressive, but show signs of growth, according to data revealed yesterday by...
Tilray Brands has announced that FL Group SRL (“FL Group”), a division of Tilray Medical in Italy, has received approval from the Italian Ministry of Health to...
A press release published on 6 September by Tilray Brands, entitled “Tilray starts roundtable with German regulators to launch bill to...
A new educational platform was launched this week by Tilray Medical, with the aim of informing healthcare professionals, caregivers and patients about the use...
Infarmed confirmed today to Cannareporter that it has already received 97 licensing applications for the activities of growing, manufacturing, importing and exporting cannabis for the...
The first Infarmed-approved cannabis flowers have been available in Portuguese pharmacies since the beginning of April, but Tilray does not reveal what the...